等待开盘 02-18 09:30:00 美东时间
+0.505
+0.50%
IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ:IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance
02-10 21:08
iRadimed Corporation (the "Company") (NASDAQ:IRMD), announced that its Board of Directors (the "Board") approved a special cash dividend of $0.50 per share of the Company's outstanding common stock. This special cash
2025-12-08 21:43
iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.43-$0.47 vs $0.41 analyst estimate..
2025-11-03 21:36
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
iRadimed (NASDAQ:IRMD) is gearing up to announce its quarterly earnings on Mond...
2025-11-01 04:01
Iradimed Corporation has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, enhancing MRI-compatible fluid delivery with advanced features and safety for healthcare providers and patients.
2025-05-29 12:30